SK’s French Bio Subsidiary Breaks Ground for 2nd Plant

SEOUL, June 14 (Korea Bizwire) — SK Inc.’s European bio subsidiary Yposkesi has begun the construction of its second drugmaking plant in France to ramp up its manufacturing capacity, the holding firm of South Korea’s No. 3 conglomerate SK Group said Monday. In March, SK acquired a 70 percent stake in Yposkesi, a France-based Contract [...]